Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,245 | 78 | 51.5% |
| Unspecified | $1,741 | 10 | 40.0% |
| Education | $369.92 | 4 | 8.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI US SERVICES INC. | $1,741 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $806.74 | 17 | $0 (2024) |
| ABBVIE INC. | $422.86 | 14 | $0 (2024) |
| Hill Dermaceuticals, Inc. | $292.96 | 1 | $0 (2024) |
| GENZYME CORPORATION | $255.29 | 5 | $0 (2024) |
| Lilly USA, LLC | $212.01 | 10 | $0 (2024) |
| Incyte Corporation | $110.26 | 5 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $100.15 | 4 | $0 (2024) |
| LEO Pharma Inc. | $98.58 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $67.81 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,507 | 68 | SANOFI US SERVICES INC. ($1,741) |
| 2023 | $365.84 | 4 | Janssen Biotech, Inc. ($365.84) |
| 2022 | $13.66 | 1 | PFIZER INC. ($13.66) |
| 2021 | $105.99 | 2 | Janssen Biotech, Inc. ($89.95) |
| 2019 | $149.26 | 12 | Lilly USA, LLC ($118.48) |
| 2018 | $190.47 | 2 | AbbVie, Inc. ($190.47) |
| 2017 | $25.06 | 3 | Janssen Biotech, Inc. ($14.06) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $149.95 | General |
| Category: Immunology | ||||||
| 12/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.19 | General |
| Category: Immunology | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Hill Dermaceuticals, Inc. | Tolak (Drug) | Food and Beverage | Cash or cash equivalent | $292.96 | General |
| Category: Topical | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: DERMATOLOGY | ||||||
| 09/25/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Inflammation & Immunology | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: DERMATOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Efficacy, Safety, PK, Biologics Monotherapy Study in Pts. with Moderate to Severe AD | SANOFI US SERVICES INC. | $1,741 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 3,292 | 7,278 | $556,447 | $214,288 |
| 2022 | 13 | 2,997 | 6,621 | $515,069 | $196,082 |
| 2021 | 16 | 3,184 | 6,764 | $524,377 | $210,314 |
| 2020 | 16 | 2,884 | 6,100 | $436,921 | $170,845 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,106 | 1,561 | $234,714 | $86,220 | 36.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 777 | 989 | $109,696 | $39,740 | 36.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 136 | 186 | $51,844 | $22,129 | 42.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 256 | 292 | $48,794 | $20,153 | 41.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 645 | 3,838 | $42,140 | $17,260 | 41.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 122 | 122 | $19,465 | $7,735 | 39.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 25 | 28 | $12,056 | $6,158 | 51.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 61 | 81 | $6,723 | $2,986 | 44.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 67 | 77 | $7,216 | $2,902 | 40.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $5,622 | $2,330 | 41.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 22 | 22 | $5,382 | $2,300 | 42.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 18 | $3,729 | $1,611 | 43.2% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 18 | $2,874 | $1,035 | 36.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 11 | 15 | $2,798 | $947.97 | 33.9% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $3,395 | $781.44 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,037 | 1,452 | $220,486 | $81,413 | 36.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 719 | 926 | $103,277 | $37,745 | 36.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 148 | 213 | $59,634 | $23,737 | 39.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 600 | 3,478 | $38,849 | $16,117 | 41.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 201 | 228 | $38,712 | $15,377 | 39.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 109 | 109 | $17,488 | $6,173 | 35.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 17 | 20 | $8,661 | $4,409 | 50.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 68 | 73 | $6,863 | $2,696 | 39.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 19 | 28 | $5,247 | $2,223 | 42.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 14 | 17 | $5,054 | $2,169 | 42.9% |
About Dr. John Korman, M.D
Dr. John Korman, M.D is a Internal Medicine healthcare provider based in Greer, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1306166871.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Korman, M.D has received a total of $4,357 in payments from pharmaceutical and medical device companies, with $3,507 received in 2024. These payments were reported across 92 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,245).
As a Medicare-enrolled provider, Korman has provided services to 12,357 Medicare beneficiaries, totaling 26,763 services with total Medicare billing of $791,529. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology
- Location Greer, SC
- Active Since 06/08/2010
- Last Updated 01/11/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1306166871
Products in Payments
- TREMFYA (Drug) $792.68
- Tolak (Drug) $292.96
- DUPIXENT (Biological) $255.29
- SKYRIZI (Biological) $192.69
- Humira (Biological) $190.47
- TALTZ (Drug) $189.88
- OPZELURA (Drug) $110.26
- ILUMYA (Biological) $100.15
- ADBRY (Biological) $98.58
- COSENTYX (Drug) $67.81
- Sotyktu (Drug) $63.91
- CIBINQO (Drug) $51.69
- Otezla (Drug) $44.40
- RINVOQ (Biological) $39.70
- Klisyri (Drug) $31.27
- EBGLYSS (Drug) $22.13
- Zoryve (Drug) $15.67
- STELARA (Biological) $14.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greer
Dr. Adam Scher, Md, MD
Internal Medicine — Payments: $13,117
William Ellison, M.d, M.D
Internal Medicine — Payments: $9,451
Mr. William Henry, M.d, M.D
Internal Medicine — Payments: $8,827
Mr. John Milas, M.d, M.D
Internal Medicine — Payments: $7,525
Dr. Ronak Desai, M.d, M.D
Internal Medicine — Payments: $6,881
Mrs. Humaira Khalid, M.d, M.D
Internal Medicine — Payments: $6,631